Chemoinformaics analysis of 5-Hydroxy-p-menth-6-en-2-one
| Molecular Weight | 168.236 | nRot | 1 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 42 |
| Exact Molecular Weight | 168.115 | nRing | 1 |
| Solubility: LogS | -4.22 | nHRing | 0 |
| Solubility: LogP | 5.614 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.9727 |
| nHD | 1 | BPOL | 16.9193 |
| QED | 0.271 |
| Synth | 5.741 |
| Natural Product Likeliness | 1.76 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 1 |
| Pgp-sub | 0.039 |
| HIA | 0.006 |
| CACO-2 | -5.585 |
| MDCK | 0.0000227 |
| BBB | 0.329 |
| PPB | 0.843199 |
| VDSS | 0.952 |
| FU | 0.124533 |
| CYP1A2-inh | 0.052 |
| CYP1A2-sub | 0.969 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.975 |
| CYP2c9-inh | 0.029 |
| CYP2c9-sub | 0.511 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.96 |
| CYP3a4-inh | 0.063 |
| CYP3a4-sub | 0.956 |
| CL | 8.964 |
| T12 | 0.319 |
| hERG | 0.973 |
| Ames | 0.083 |
| ROA | 0.177 |
| SkinSen | 0.838 |
| Carcinogencity | 0.038 |
| EI | 0.004 |
| Respiratory | 0.4 |
| NR-Aromatase | 0.649 |
| Antiviral | No |
| Prediction | 0.944014 |